Diversity and Inclusion in Cancer Health Equity

Third week of April is Minority Cancer Awareness Week

“Let’s Achieve Health Equity”

News & Updates

Strategies for Reducing Health Disparities

A major goal of public health is to reduce health disparities. The programs described in the MMWR Supplement, Strategies for Reducing Health Disparities—Selected CDC-Sponsored Interventions, United States, 2016, are examples of CDC-sponsored initiatives that address health disparities with the goal of advancing health equity.

OncLive

ASCO Report Outlines Progress Made Toward Reducing Cancer Disparities For LGBTQ+ Individuals

In a new report, ASCO highlighted progress that has been made toward reducing disparities in cancer health among sexual and gender minority (SGM) individuals, although they stressed that additional progress is still needed in this area. The report, which was published in JCO Oncology Practice, served as an update on ASCO’s 2017 position statement “Strategies...

Cleveland Clinic of Florida

S1826 clinical trial for advanced Hodgkin lymphoma

Accrual of the S1826 clinical trial for advanced Hodgkin lymphoma will likely shift treatment modality. Remarkable was the diversity reported for the collaborative study for the first time of the adult and pediatric cooperative research groups.It was the largest Hodgkin lymphoma trial conducted by the National Clinical Trials Network (NCTN) with a highly representative group:...

Genentech

Genentech: Diversity & Inclusion

We firmly believe that embracing diversity and inclusion (D&I) drives innovation, improves scientific and clinical outcomes, and contributes to equitable healthcare access for all. Here at Genentech, that means fostering belonging within our own walls, advancing inclusive research and health equity in our industry at-large, and transforming society through partnerships across healthcare, education and within all communities. Please learn more HERE.

CancerCoachLive

CancerCoachLive Offers Webinars On Health Equity

CancerCoachLive partners with leading clinical specialists and advocacy organizations to bring free online education to cancer patients and caregivers. CancerCoachLive’s programs are broadcast live through our virtual learning channel, including a panel of experts, interactive Q&A, polling and slides for an immersive learning experience. All of their programmings are available on demand following the live...

JCO Oncology Practice

Toward Achieving Equity in Cancer Clinical Trials

“Racial and ethnic minorities who are traditionally underrepresented in clinical trials have also had worse clinical outcomes over time. Black patients, for example, have a clinical trial enrollment rate of 4%-6% despite representing 15% of the population and have the highest overall cancer death rate. It has been established that numerous barriers to clinical trial participation exist at...

Health Equity Train the Trainer Program

Health Equity Train the Trainer Program, an award-winning training program that is funded by the Florida Blue Foundation, in partnership with Orlando Health, Moffitt Cancer Center, and United Way Broward is a six-week long program with a 10-hour time commitment. There are two live zoom sessions (5 hours total) and 6 modules (5 hours total)...

FLASCO

2022 Cancer Disparities & Health Equity Summit

Professionals from academia, industry, and the community are coming together with the shared mission of closing health equity gaps and developing and sustaining diversity and inclusion efforts in the health system of Florida. Together they will promote the exchange of novel ideas, discuss the latest findings in the field, and stimulate the development of new research, advocacy, and policy on cancer disparities.

FLASCO

Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery

J Natl Compr Canc Netw. 2022;20(10):1092-1098.e2. Schatz AA, Brooks-Coley K, Harrington E, Murray MS, Carlson RW. Cancer prevention and treatment systems are significantly impacted by interpersonal, organizational, and structural and systemic racism. A wide body of research has found that racial disparities in access to guideline-adherent cancer care are pervasive throughout the United States and...

 

Publications

Cancer Treatment Disparities | AACR Cancer Disparities Progess Report 2020

American Cancer Society’s report on the status of cancer disparities in the United States, 2021.

Cancer statistics for African American/Black People 2022

Cancer statistics for the US Hispanic/Latino population, 2021

Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare.

Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology

AACR REPORT ON THE IMPACT OF COVID-19 ON CANCER RESEARCH AND PATIENT CARE

Advancing Health Equity: A Guide to Language, Narrative and Concepts


Raez, Luis

Raez LE, Santos ES, Rolfo C, et al. Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America. Clin Lung Cancer. 2017;18(1):e71-e79.

Raez LE, Cardona AF, Santos ES, et al. The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. Lung Cancer. 2018;119:7-13.

Raez LE, Nogueira A, Santos ES, et al. Challenges in Lung Cancer Screening in Latin America. J Glob Oncol. 2018;4:1-10.

Pinto JA, Raez LE. Old myths about old patients: the case of non-small cell lung cancer. Transl Lung Cancer Res. 2018;7(Suppl 4):S362-S363.

Johnstone, Peter

Johnstone PA, Kane CJ, Sun L, et al. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002;225(2):420-426.

Beitinjaneh, Amer Morris

Wood WA, Brazauskas R, Hu ZH, et al. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. Biol Blood Marrow Transplant. 2018;24(9):1928-1935.

Blanquicett,  Carmelo J

Blanquicett C, Cohen JB, Flowers C, Johnson T 2nd. The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient. Oncology (Williston Park). 2019;33(11):687524. Published 2019 Nov 14.

Farooqi, Bilal

Farooqi B, Smith B, Chowdhary M, Pavoni S, Modi A, Schnell F. Racial disparities in breast cancer diagnosis in Central Georgia in the United States. J Community Support Oncol. 2015;13(12):436-441.

Sanchez, Julian A

Schabath MB, Blackburn CA, Sutter ME, et al. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. J Clin Oncol. 2019;37(7):547-558.

Quinn GP, Sanchez JA, Sutton SK, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384-400.

Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers’ knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016;99(10):1676-1684.

Schabath MB, Curci MB, Kanetsky PA, et al. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017;13(8):542-546.

Ailawadhi, Sikander

Ganguly S, Mailankody S, Ailawadhi S. Many Shades of Disparities in Myeloma Care. Am Soc Clin Oncol Educ Book. 2019;39:519-529.

Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 2019;3(20):2986-2994.

Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood Cancer J. 2018;8(7):67.

Ailawadhi S, Frank RD, Sharma M, et al. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities. Cancer. 2018;124(8):1710-1721.

Rand KA, Song C, Dean E, et al. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev. 2016;25(12):1609-1618.

Ailawadhi S, Frank RD, Advani P, et al. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis. Cancer Med. 2017;6(12):2876-2885.

Ailawadhi S, Azzouqa AG, Hodge D, et al. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities. Clin Lymphoma Myeloma Leuk. 2019;19(10):619-623.

Nahleh, Zeina

Nahleh Z, Otoukesh S, Mirshahidi HR, et al. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med. 2018;7(6):2710-2717.

Charlot M

Charlot M, Stein JN, Damone E, Wood I, Forster M, Baker S, Emerson M, Samuel-Ryals C, Yongue C, Eng E, Manning M, Deal A, Cykert S. Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer Surgery. J Clin Oncol. 2022 Feb 14:JCO2101745. doi: 10.1200/JCO.21.01745.

Schatz, A. A., Brooks-Coley, K., Harrington, E., Murray, M. S., & Carlson, R. W.

Schatz, A. A., Brooks-Coley, K., Harrington, E., Murray, M. S., & Carlson, R. W. (2022). Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery, Journal of the National Comprehensive Cancer Network, 20(10), 1092-1098.e2. from https://jnccn.org/view/journals/jnccn/20/10/article-p1092.xml

Non English Resources

Other Links

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO